CD274 and non-small cell lung carcinoma: For example, non-small cell lung cancer (NSCLC) patients who did not respond to anti-PD-L1/PD-1 monotherapies had highly dysfunctional T cells that strongly co-expressed PD-1 and LAG-3 after TCR stimulation [22].